SE8503164L - Stabilisator - Google Patents

Stabilisator

Info

Publication number
SE8503164L
SE8503164L SE8503164A SE8503164A SE8503164L SE 8503164 L SE8503164 L SE 8503164L SE 8503164 A SE8503164 A SE 8503164A SE 8503164 A SE8503164 A SE 8503164A SE 8503164 L SE8503164 L SE 8503164L
Authority
SE
Sweden
Prior art keywords
reduce
stabilizer
cadmium
isomer
inhibit
Prior art date
Application number
SE8503164A
Other languages
English (en)
Other versions
SE8503164D0 (sv
Inventor
Matti Siren
Original Assignee
Matti Siren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matti Siren filed Critical Matti Siren
Publication of SE8503164D0 publication Critical patent/SE8503164D0/sv
Priority to US06/788,830 priority Critical patent/US4735902A/en
Priority to EP85113384A priority patent/EP0179442B1/en
Priority to CA000493572A priority patent/CA1337338C/en
Priority to DE8585113384T priority patent/DE3581691D1/de
Priority to AU48933/85A priority patent/AU598727B2/en
Priority to SE8504970A priority patent/SE458121B/sv
Priority to DE19853537563 priority patent/DE3537563A1/de
Priority to DK483485A priority patent/DK483485A/da
Priority to GB08526081A priority patent/GB2167420B/en
Priority to AT85113384T priority patent/ATE60774T1/de
Publication of SE8503164L publication Critical patent/SE8503164L/sv
Priority to US07/015,698 priority patent/US4793945A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/30—Organic phosphorus compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVING, e.g. BY CANNING, MEAT, FISH, EGGS, FRUIT, VEGETABLES, EDIBLE SEEDS; CHEMICAL RIPENING OF FRUIT OR VEGETABLES; THE PRESERVED, RIPENED, OR CANNED PRODUCTS
    • A23B7/00—Preservation or chemical ripening of fruit or vegetables
    • A23B7/14—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10
    • A23B7/153—Preserving or ripening with chemicals not covered by groups A23B7/08 or A23B7/10 in the form of liquids or solids
    • A23B7/154—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/05—Organic compounds containing phosphorus as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3553—Organic compounds containing phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
SE8503164A 1984-10-23 1985-06-26 Stabilisator SE8503164L (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US06/788,830 US4735902A (en) 1984-10-23 1985-10-18 Stabilized composition containing inositoltriphosphate
AT85113384T ATE60774T1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
AU48933/85A AU598727B2 (en) 1984-10-23 1985-10-22 Stabilized composition containing inositoltriphosphate
CA000493572A CA1337338C (en) 1984-10-23 1985-10-22 Inositoltriphosphate
DE8585113384T DE3581691D1 (de) 1984-10-23 1985-10-22 Inositoltriphosphat enthaltende stabilisierte zusammensetzung und verfahren zur stabilisierung der zusammensetzung.
EP85113384A EP0179442B1 (en) 1984-10-23 1985-10-22 Stabilized composition containing inositoltriphosphate and method for stabilizing the composition
SE8504970A SE458121B (sv) 1984-10-23 1985-10-22 Stabiliserad komposition samt foerfarande foer stabilisering
DE19853537563 DE3537563A1 (de) 1984-10-23 1985-10-22 Stabilisierte zusammensetzung mit einem gehalt an inositoltriphosphat und verfahren zu deren herstellung
DK483485A DK483485A (da) 1984-10-23 1985-10-22 Stabiliseret praeparat indeholdende inositoltriphosphat
GB08526081A GB2167420B (en) 1984-10-23 1985-10-22 Improvements in or relating to a stabilized compositions containing inositoltriphosphate
US07/015,698 US4793945A (en) 1984-10-23 1987-02-17 Use of inositol triphosphate as a stabilizer and compositions formed therefrom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav

Publications (2)

Publication Number Publication Date
SE8503164D0 SE8503164D0 (sv) 1985-06-26
SE8503164L true SE8503164L (sv) 1986-04-24

Family

ID=20357457

Family Applications (6)

Application Number Title Priority Date Filing Date
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
SE8503164A SE8503164L (sv) 1984-10-23 1985-06-26 Stabilisator
SE8503165A SE8503165L (sv) 1984-10-23 1985-06-26 Stabilisator ii
SE8504968A SE465164B (sv) 1984-10-23 1985-10-22 Inositoltrifosfat, ett foerfarande foer framstaellning daerav och en komposition innehaallande detta
SE8504969A SE8504969L (sv) 1984-10-23 1985-10-22 Forfarande for framstellning av en livsmedelskomposition innehallande inositoltrifosfat och kompositionen
SE8504967A SE8504967L (sv) 1984-10-23 1985-10-22 Farmaceutisk komposition och forfarande for behandling av kroppen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE8405295A SE465951B (sv) 1984-10-23 1984-10-23 Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav

Family Applications After (4)

Application Number Title Priority Date Filing Date
SE8503165A SE8503165L (sv) 1984-10-23 1985-06-26 Stabilisator ii
SE8504968A SE465164B (sv) 1984-10-23 1985-10-22 Inositoltrifosfat, ett foerfarande foer framstaellning daerav och en komposition innehaallande detta
SE8504969A SE8504969L (sv) 1984-10-23 1985-10-22 Forfarande for framstellning av en livsmedelskomposition innehallande inositoltrifosfat och kompositionen
SE8504967A SE8504967L (sv) 1984-10-23 1985-10-22 Farmaceutisk komposition och forfarande for behandling av kroppen

Country Status (19)

Country Link
US (7) US4734283A (sv)
EP (3) EP0179440B1 (sv)
JP (4) JPS61181347A (sv)
AT (3) ATE41853T1 (sv)
AU (3) AU582594B2 (sv)
BE (2) BE903497A (sv)
CH (2) CH668597A5 (sv)
DE (6) DE3565464D1 (sv)
DK (2) DK172857B1 (sv)
FI (3) FI85490C (sv)
FR (2) FR2571967B1 (sv)
GB (3) GB2167283B (sv)
HU (1) HU196077B (sv)
IL (1) IL76777A (sv)
IT (2) IT1190402B (sv)
NO (3) NO168227C (sv)
NZ (1) NZ213855A (sv)
SE (6) SE465951B (sv)
ZA (4) ZA858108B (sv)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095035A (en) * 1981-07-31 1992-03-10 Eby Iii George A Flavor stable zinc acetate compositions for oral absorption
SE465305B (sv) * 1986-04-16 1991-08-26 Perstorp Ab Anvaendning av inositolfosfat foer framstaellning av ett laekemedel
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
US5330979A (en) * 1984-10-23 1994-07-19 Perstorp Ab Method of treating renal disorders with inositoltriphosphate
US5407924A (en) * 1984-10-23 1995-04-18 Perstorp Ab Method of treating pain using inositol triphosphate
SE465951B (sv) 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
US5128332A (en) * 1984-10-23 1992-07-07 Perstorp Ab Method of treating cardiovascular diseases using inositoltrisphosphate
EP0262227B1 (en) * 1986-03-11 1993-01-20 MITSUI TOATSU CHEMICALS, Inc. Process for the preparation of myoinositol derivatives
JPS63198642A (ja) * 1986-03-11 1988-08-17 Mitsui Toatsu Chem Inc ミオイノシトール誘導体の製造方法
US5057507A (en) * 1986-04-16 1991-10-15 Perstorp Ab Method of alleviating bone damage with inositoltriphosphate
WO1988003365A1 (en) * 1986-11-05 1988-05-19 George Weston Foods Limited Novel improvers for flour and yeast raised baked goods
SE8605063D0 (sv) * 1986-11-26 1986-11-26 Matti Siren Derivatives of cyclohexane
US5274161A (en) * 1986-11-26 1993-12-28 Perstorp Ab Derivatives of cyclohexane
GB8705811D0 (en) * 1987-03-11 1987-04-15 Research Corp Ltd Inositol derivatives
JP2597618B2 (ja) * 1987-12-28 1997-04-09 三井東圧化学 株式会社 光学分割方法
JPH01287035A (ja) * 1988-05-13 1989-11-17 Sanwa Kagaku Kenkyusho Co Ltd 薬物並びにアルコール性中毒の予防剤とその治療剤
JPH01294631A (ja) * 1988-05-19 1989-11-28 Sanwa Kagaku Kenkyusho Co Ltd 糖尿性疾患治療予防剤及び飲食、し好物
SE464059C (sv) * 1988-09-15 1997-06-02 Perstorp Ab Användning av inositoltrifosfat för framställning av läkemedel
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5750348A (en) * 1989-03-08 1998-05-12 The University Of Virginia Patents Foundation Method for detecting insulin resistance
US5428066A (en) * 1989-03-08 1995-06-27 Larner; Joseph Method of reducing elevated blood sugar in humans
JPH04504847A (ja) * 1989-03-08 1992-08-27 ザ　ユニバーシティ　オヴ　バージニア　パテント　ファウンデーション インスリン抵抗性糖尿病のための食事用補添物
US5427956A (en) * 1989-03-08 1995-06-27 The University Of Virginia Patent Foundation Quantitative analysis for diabetic condition predictor
SE8902766D0 (sv) * 1989-08-17 1989-08-17 Siren Matti Saett att oeka den farmaceutiska effekten av inositolfosfat samt en beredning med foerbaettrad farmaceutisk effekt
SE8904355D0 (sv) * 1989-12-21 1989-12-21 Perstorp Ab Medicament
US7033627B2 (en) 1990-03-23 2006-04-25 Syngenta Mogen B.V. Production of enzymes in seeds and their use
KR100225087B1 (ko) * 1990-03-23 1999-10-15 한스 발터라벤 피타아제의 식물내 발현
US5543576A (en) * 1990-03-23 1996-08-06 Mogen International Production of enzymes in seeds and their use
US5593963A (en) * 1990-09-21 1997-01-14 Mogen International Expression of phytase in plants
SE9002278L (sv) * 1990-06-28 1991-12-29 Perstorp Ab Anvaendning av inositoltrisfosfat foer framstaellning av ett laekemedel
JP3266249B2 (ja) * 1990-08-29 2002-03-18 スターリング チェイキン タマネギ又はニンニクのような野菜を食べることによる望ましくない副作用の除去方法及び生成物
US6007809A (en) * 1990-08-29 1999-12-28 Chaykin; Sterling Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
US5514398A (en) * 1990-11-05 1996-05-07 Amano Pharmaceutical Co., Ltd. Food additive and use thereof
SE9102068L (sv) * 1991-07-03 1993-01-04 Perstorp Ab Derivat av inositol, kompositioner innehaallande dessa samt anvaendning daerav
SE469260B (sv) * 1992-02-25 1993-06-14 Perstorp Ab En farmaceutisk komposition med foerbaettrad biotillgaenglighet avseende inositolfosfat
US5292537A (en) * 1992-11-12 1994-03-08 Bran Tec, Inc. Method for stabilizing rice bran and rice bran products
JP2696057B2 (ja) * 1993-05-11 1998-01-14 ニチモウ株式会社 穀類を原料とした生成物の製造方法
WO1995005830A1 (en) * 1993-08-20 1995-03-02 The Regents Of The University Of California Polyanion anti-inflammatory agents
SE502989C2 (sv) * 1993-11-22 1996-03-04 Perstorp Ab Användning av en inositoltrisfosfatester för beredning av läkemedel
SE503122C2 (sv) * 1993-11-22 1996-03-25 Perstorp Ab Användning av en inositoltrisfosfatester för behandling av inflammatoriska tillstånd
US5466465A (en) * 1993-12-30 1995-11-14 Harrogate Holdings, Limited Transdermal drug delivery system
SE502574C2 (sv) * 1994-01-25 1995-11-13 Perstorp Ab En farmaceutisk komposition med förbättrad biotillgänglighet hos inositolfosfat
US6451572B1 (en) 1998-06-25 2002-09-17 Cornell Research Foundation, Inc. Overexpression of phytase genes in yeast systems
ES2248067T3 (es) 1999-03-31 2006-03-16 Cornell Research Foundation, Inc. Fosfatasas con actividad de fitasa mejorada.
US6841370B1 (en) 1999-11-18 2005-01-11 Cornell Research Foundation, Inc. Site-directed mutagenesis of Escherichia coli phytase
US6383817B2 (en) 1999-12-30 2002-05-07 Wake Forest University Cadmium is a risk factor for human pancreatic cancer
US20020193379A1 (en) * 2001-06-05 2002-12-19 Insmed Incorporated Compositions and methods for decreasing the risk of or preventing neural tube disorders in mammals
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
EP2335501B8 (en) * 2001-10-31 2016-09-21 Huvepharma Eood Phytase-containing animal food and method
US20050108780A1 (en) * 2002-01-24 2005-05-19 Erasmus University Intracellular antibodies for a retrovirus protein
AU2003231157C1 (en) 2002-04-29 2009-02-26 Normoxys, Inc. Inositol pyrophosphates, and methods of use thereof
EP1604008B1 (en) * 2002-09-13 2010-12-22 Cornell Research Foundation, Inc. Using mutations to improve aspergillus phytases
CA2413240A1 (en) * 2002-11-29 2004-05-29 Mcn Bioproducts Inc. Purification of inositol from plant materials
US20050123644A1 (en) * 2003-01-24 2005-06-09 Cargill, Incorporated Phosphate-containing fertilizer derived from steepwater
US7521481B2 (en) * 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
US20050048165A1 (en) * 2003-03-31 2005-03-03 Sadanandan Bindu Process for the preparation of Chapathi dough with reduced phytic acid level
US20060258626A1 (en) * 2004-07-06 2006-11-16 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
US20070135389A1 (en) * 2004-07-06 2007-06-14 Claude Nicolau Tumor eradication by inositol-tripyrophosphate
US7745423B2 (en) * 2004-07-06 2010-06-29 NormOxys, Inc Calcium/sodium salt of inositol tripyrophosphate as an allosteric effector of hemoglobin
US20060106000A1 (en) * 2004-07-06 2006-05-18 Claude Nicolau Use of inositol-tripyrophosphate in treating tumors and diseases
EP1863495B1 (en) * 2005-03-18 2015-02-18 NormOxys, Inc. Calcium and sodium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate for treating cancer
US7919297B2 (en) 2006-02-21 2011-04-05 Cornell Research Foundation, Inc. Mutants of Aspergillus niger PhyA phytase and Aspergillus fumigatus phytase
US20070212449A1 (en) * 2006-03-02 2007-09-13 Shamsuddin Abulkalam M Reduction of the titratable acidity and the prevention of tooth and other bone degeneration
EP2069486A2 (en) * 2006-08-03 2009-06-17 Cornell Research Foundation, Inc. Phytases with improved thermal stability
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof
US20110218176A1 (en) 2006-11-01 2011-09-08 Barbara Brooke Jennings-Spring Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
US20090214474A1 (en) * 2006-11-01 2009-08-27 Barbara Brooke Jennings Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
AU2008246061A1 (en) * 2007-05-01 2008-11-06 Normoxys, Inc. Erythropoietin complementation or replacement
US8192734B2 (en) 2007-07-09 2012-06-05 Cornell University Compositions and methods for bone strengthening
EP2187892A1 (en) * 2007-09-17 2010-05-26 Bioneris AB Method and means for the treatment of cachexia
ES2604110T3 (es) * 2011-07-01 2017-03-03 Shiseido Company, Ltd. Activador de la producción del factor de crecimiento derivado de plaquetas-BB, y activador de la producción de células madre mesenquimatosas, estabilizador de células madre y regenerador de la dermis comprendiendo cada uno el mismo
FR3017134B1 (fr) * 2014-02-06 2018-04-20 Lesaffre Et Compagnie Levure biologique, procede d'obtention et utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2723938A (en) * 1952-12-05 1955-11-15 Bristol Lab Inc Aqueous penicillin suspensions comprising inositol phosphoric acids and their salts
US3591665A (en) * 1967-09-08 1971-07-06 Mitsui Toatsu Chemicals Process for producing phytic acid
FI51469C (sv) * 1968-01-10 1977-01-10 Morinaga Milk Industry Co Ltd Förfarande för avlägsning av radioaktivt strontium 90 ur flytande livs medel eller vatten.
JPS50111246A (sv) * 1974-02-14 1975-09-01
US4154824A (en) * 1976-07-20 1979-05-15 Interx Research Corporation Nonbitter tasting potassium product for oral administration to warm-blooded animals and method for preparing same
JPS53124636A (en) * 1977-04-04 1978-10-31 Kisaku Mori Method of increasing meranine contained in animal and plant
DE2740053A1 (de) * 1977-09-06 1979-05-03 Klaus Prof Dr Med Gersonde Verwendung von allosterischen effektoren mit hilfe von lipidvesikeln ueber eine irreversible inkorporierung zwecks verbesserter o tief 2 -entladung des haemoglobins in erythrozyten
JPS5486666A (en) * 1977-12-22 1979-07-10 Ajinomoto Kk Cola beverage
JPS5798292A (en) * 1980-12-09 1982-06-18 Jiyaade:Kk Powdery phytic acid and its preparation
JPS58198254A (ja) * 1982-05-14 1983-11-18 Kyowa Hakko Kogyo Co Ltd 加工食品の品質改良法
SE450325B (sv) * 1983-02-23 1987-06-22 Tricum Ab Kostfiberprodukt baserad pa skaldelar fran froet hos ceralier
US4735902A (en) * 1984-10-23 1988-04-05 Matti Siren Stabilized composition containing inositoltriphosphate
SE465951B (sv) * 1984-10-23 1991-11-25 Perstorp Ab Isomer av inositoltrifosfat foeretraedesvis i saltform foer anvaendning som terapeutiskt eller profylaktiskt medel samt kompositioner daerav
WO2001079440A2 (en) 2000-04-13 2001-10-25 Novozymes A/S Extracellular expression of pectate lyase using bacillus or escherichia coli

Also Published As

Publication number Publication date
IT8522573A0 (it) 1985-10-22
SE8504969L (sv) 1986-04-24
SE465164B (sv) 1991-08-05
GB8526080D0 (en) 1985-11-27
ZA858107B (en) 1986-06-25
ZA858105B (en) 1986-06-25
FI854126A0 (fi) 1985-10-22
AU589378B2 (en) 1989-10-12
US4851560A (en) 1989-07-25
FI85490C (sv) 1992-04-27
EP0179441B1 (en) 1989-04-05
JPH0338824B2 (sv) 1991-06-11
DE3577851D1 (de) 1990-06-28
NO168227C (no) 1992-01-29
FI88855C (sv) 1993-07-26
GB2167283B (en) 1989-05-24
FI854127A0 (fi) 1985-10-22
JPS61181347A (ja) 1986-08-14
FI82474B (fi) 1990-11-30
US4794014A (en) 1988-12-27
JPS61171491A (ja) 1986-08-02
FI854127L (fi) 1986-04-24
DE3565464D1 (en) 1988-11-17
US5003098A (en) 1991-03-26
IL76777A (en) 1990-09-17
AU4893085A (en) 1986-05-01
DE3537542A1 (de) 1986-05-15
US4734283A (en) 1988-03-29
DK172857B1 (da) 1999-08-16
DK483285D0 (da) 1985-10-22
US4797390A (en) 1989-01-10
SE8504967D0 (sv) 1985-10-22
GB2169602B (en) 1988-10-19
SE8503165D0 (sv) 1985-06-26
IL76777A0 (en) 1986-02-28
IT1190402B (it) 1988-02-16
BE903498A (fr) 1986-02-17
JPH0354924B2 (sv) 1991-08-21
EP0179441A2 (en) 1986-04-30
ZA858108B (en) 1986-06-25
NO854213L (no) 1986-04-24
CH666812A5 (fr) 1988-08-31
AU4893285A (en) 1986-05-01
ATE37788T1 (de) 1988-10-15
AU596080B2 (en) 1990-04-26
EP0179439B1 (en) 1988-10-12
GB2169602A (en) 1986-07-16
ATE53038T1 (de) 1990-06-15
GB2167298A (en) 1986-05-29
SE8503164D0 (sv) 1985-06-26
FI854128L (fi) 1986-04-24
NZ213855A (en) 1989-05-29
GB2167298B (en) 1988-11-02
ATE41853T1 (de) 1989-04-15
BE903497A (fr) 1986-02-17
DE3537550A1 (de) 1986-05-15
DK483385D0 (da) 1985-10-22
US4777134A (en) 1988-10-11
GB8526079D0 (en) 1985-11-27
DK483385A (da) 1986-04-24
IT1190403B (it) 1988-02-16
SE8405295L (sv) 1986-04-24
JPH0515719B2 (sv) 1993-03-02
SE8503165L (sv) 1986-04-24
NO854211L (no) 1986-04-24
DK172852B1 (da) 1999-08-16
SE8504968L (sv) 1986-04-24
HU196077B (en) 1988-09-28
EP0179440A1 (en) 1986-04-30
DE3569188D1 (en) 1989-05-11
EP0179441A3 (en) 1988-03-16
SE465951B (sv) 1991-11-25
CH668597A5 (fr) 1989-01-13
DE3537569A1 (de) 1986-05-22
EP0179439A1 (en) 1986-04-30
NO169010B (no) 1992-01-20
NO169010C (no) 1992-04-29
GB2167283A (en) 1986-05-29
FI82474C (sv) 1991-03-11
FI85490B (fi) 1992-01-15
FI854126L (fi) 1986-04-24
NO168227B (no) 1991-10-21
HUT40674A (en) 1987-01-28
FR2571967B1 (fr) 1988-02-05
SE8504969D0 (sv) 1985-10-22
AU582594B2 (en) 1989-04-06
DK483285A (da) 1986-04-24
ZA858106B (en) 1986-06-25
FI88855B (fi) 1993-04-15
US4735936A (en) 1988-04-05
NO854212L (no) 1986-04-24
FI854128A0 (fi) 1985-10-22
FR2573080A1 (fr) 1986-05-16
AU4893185A (en) 1986-05-01
GB8526078D0 (en) 1985-11-27
JPS61171422A (ja) 1986-08-02
JPH037233B2 (sv) 1991-02-01
FR2573080B1 (fr) 1988-11-10
SE8504968D0 (sv) 1985-10-22
JPS61171789A (ja) 1986-08-02
SE8504967L (sv) 1986-04-24
IT8522574A0 (it) 1985-10-22
SE8405295D0 (sv) 1984-10-23
FR2571967A1 (fr) 1986-04-25
EP0179440B1 (en) 1990-05-23

Similar Documents

Publication Publication Date Title
SE8503164D0 (sv) Stabilisator

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8503164-9

Effective date: 19871114